Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

News

Rescheduling Cannabis Doesn’t End Prohibition’s Harms…

The executive order to reschedule cannabis marks a symbolic victory and a recalibration of decades of federal misclassification. Reclassifying cannabis as a Schedule III substance is a long-overdue acknowledgment …
December 18, 2025

Ohio State’s Center for Psychedelic Drug Research and Education collaborates with MAPS for the Ohio P.E.A.C.E. program

Using funding provided by the Ohio Department of Behavioral Health, the Center for Psychedelic Drug Research and Education (CPDRE) will equip more than 127,000 Ohio professionals with skills in psychedelic …
November 17, 2025

MAPS and HoloMind Institute Host International MDMA-Assisted Therapy Training in Poland

San Jose, CA | October 6, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization at the vanguard of the psychedelic movement since 1986, is partnering …
October 8, 2025

MAPS Board of Directors Names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors

September 9, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization at the vanguard of the psychedelic movement since 1986, today announced that its …
September 9, 2025

MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy

San Jose, CA; September 4, 2025 — In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy …
September 4, 2025

MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans

August 27, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced today that it has selected Changemark Research + Evaluation (Changemark) as its contract research organization …
August 27, 2025

MAPS Urges Action: Open Letter to HHS Secretary and FDA Commissioner One Year After FDA Denial of MDMA-Assisted Therapy for PTSD

WASHINGTON, DC (August 14, 2025) — One year after the FDA’s denial of the New Drug Application for MDMA-assisted therapy for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) has …
August 14, 2025

Statement: Confirmation of DEA Administrator Terrance C. Cole

On Tuesday, the Senate officially confirmed Terrance Cole as the new Administrator of the Drug Enforcement Administration (DEA), marking the first permanent leadership appointment to the agency under President …
July 23, 2025

Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos

July 16, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the launch of its enhanced Virtual Trip video conference platform featuring the first selection of videos from …
July 16, 2025

Plant Medicine Track at Psychedelic Science 2025 Spotlights Ancestral Wisdom, Indigenous Sovereignty, and Being in Right Relationship

DENVER, June 12, 2025 (GLOBE NEWSWIRE) — With growing recognition of psychedelics and plant medicines in therapeutic and scientific settings, it is a critical time to uplift and acknowledge the Indigenous …
June 12, 2025

Sound, Spirit, and Celebration: Maejor, Jim James, and Vic Mensa Lead the Musical Heartbeat of Psychedelic Science 2025

• Music Is the Bridge: Frequencies, Visions, Creativity Session at PS2025 Explores the Role of Sound in Emotional Integration, Brainwave Regulation, and Therapeutic Breakthroughs • Reggie Watts, Flying …
June 4, 2025

Legislators, Advocates, Lawyers, and Organizers Take the Stage during Policy Track at Psychedelic Science 2025 to Shape the Future of Psychedelic Reform

DENVER, May 30, 2025 — In the last year, we’ve seen the first-ever FDA review of psychedelic-assisted therapy and state legislatures debating—and passing—bills to create legal access across the …
May 30, 2025

Posts pagination

Page 1 … Page 29 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide